APA

Fitzgerald D. W., Janes H., Robertson M., Coombs R., Frank I., Gilbert P., Loufty M., Mehrotra D. & Duerr A. (20110415). An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study). : The Journal of infectious diseases.

Chicago

Fitzgerald D W, Janes H, Robertson M, Coombs R, Frank I, Gilbert P, Loufty M, Mehrotra D and Duerr A. 20110415. An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study). : The Journal of infectious diseases.

Harvard

Fitzgerald D. W., Janes H., Robertson M., Coombs R., Frank I., Gilbert P., Loufty M., Mehrotra D. and Duerr A. (20110415). An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study). : The Journal of infectious diseases.

MLA

Fitzgerald D W, Janes H, Robertson M, Coombs R, Frank I, Gilbert P, Loufty M, Mehrotra D and Duerr A. An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study). : The Journal of infectious diseases. 20110415.